Search
CeriBell Inc
CBLLAdd to Watchlist
17.700USD
+0.010+0.06%
Close 07-31 16:00（ET）Quotes delayed by 15 min
670.12MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of CeriBell Inc is 9.25, ranking 2 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 29.00, with a high of 32.00 and a low of 17.00.
Analyst Rating
Based on
8
analysts
Strong Buy
Current Rating
26.857
Target Price
+51.82%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
CeriBell Inc
CBLL
8
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is CeriBell Inc's expected revenue for the next quarter?
CeriBell Inc's expected revenue is 27.28M.
What is CeriBell Inc's price target?
Analysts forecast that CeriBell Inc's price target is USD 29.00, with the highest forecast at USD 32.00 and the lowest forecast at USD 17.00.
How have CeriBell IncCBLL's recent earnings per share performed?
The market expectation was USD -0.52, while CeriBell IncCBLL's earnings per share (EPS) for the previous quarter was USD -0.36. EPS for the next quarter is expected at USD -0.47.
What is the analyst rating for CeriBell Inc?
Based on the ratings of CeriBell Inc's stock from 8 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.